Post Profile






Combination strategy could hold promise for ovarian cancer

Mice with ovarian cancer that received drugs to reactivate dormant genes along with other drugs that activate the immune system had a greater reduction of tumor burden and significantly longer survival than those that received any of the drugs alone, report investigators.
read more

share

Related Posts


First Model Of Aggressive Ovarian Cancer Demonstrates Immune System's Active Role In Tumor Progression

Health : Medical News Today

Aggressive ovarian tumors begin as malignant cells kept in check by the immune system until, suddenly and unpredictably, they explode into metastatic cancer. New findings from scientists at The Wistar Institute demonstrate that ovar...

Novel cancer vaccine holds promise against ovarian cancer, mesothelioma

Health : Medical News Today

A novel approach to cancer immunotherapy - strategies designed to induce the immune system to attack cancer cells - may provide a new and cost-effective weapon against some of the most deadly tumors, including ovarian cancer and mes...

More Tumor Mutations Equals Higher Success Rate With Cancer Immunotherapy Drugs

Health : Newswise Medical News

The "mutational burden," or the number of mutations present in a tumor's DNA, is a good predictor of whether that cancer type will respond to a class of cancer immunotherapy drugs known as checkpoint inhibitors, a new study led by J...

More tumor mutations equals higher success rate with cancer immunotherapy drugs

Diseases & Conditions / Cancer : EurekAlert: Cancer

(Johns Hopkins Medicine) The mutational burden, or the number of mutations present in a tumors DNA, is a good predictor of whether that cancer type will respond to a class of cancer immunotherapy drugs known as checkpoint inhibitors...

Combination Strategy Could Hold Promise for Ovarian Cancer

Health : Newswise Medical News

Johns Hopkins Kimmel Cancer Center researchers demonstrated that mice with ovarian cancer that received drugs to reactivate dormant genes along with other drugs that activate the immune system had a greater reduction of tumor burden...

Comments


Copyright © 2016 Regator, LLC